Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mouse

Oncogene

Volumn 18, Issue 6, 1999, Pages 1297-1302

  Balasubramanian, Sivaprakasam ^a   Kim, Ki Ho ^a,b   Ahmad, Nihal ^a   Mukhtar, Hasan ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Dong A University College of Medicine   (South Korea)

Author keywords

Cell cycle; Cyclin; Cyclin dependent; Cyclin dependent kinase inhibitor; Kinase; Skin carcinogenesis; Telomerase

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; TELOMERASE;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CARCINOMA; CELL CYCLE G1 PHASE; CELL GROWTH; CELL IMMORTALIZATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EPIDERMIS; FEMALE; MOUSE; NEOPLASM; NONHUMAN; NUCLEOTIDE REPEAT; NUDE MOUSE; PAPILLOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RECEPTOR UPREGULATION; SKIN CANCER; ULTRAVIOLET B RADIATION;

EID: 0033545408     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202417     Document Type: Article

References (39)

1. Balasubramanian S, Ahmad N, Jeedigunta S and Mukhtar H. (1998). Biochem. Biophys. Res. Commun., 243, 744-748.
2. Bednarek A, Budunova I, Slaga TJ and Aldaz CM. (1995). Cancer Res., 55, 4566-4569.
3. Bednarek A, Chu Y, Slaga TJ and Aldaz CM. (1997). Mol. Carcinog., 20, 329-331.
4. Bianchi AB, Fischer SM, Robles AI, Rinchik EM and Conti CJ. (1993). Oncogene, 8, 1127-1133.
5. Blasco MA, Rizen M, Grieder CW and Hanahan D. (1996). Nature Genet., 12, 200-204.
6. Broccoli D, Young JW and de Lange T. (1995). Proc. Natl. Acad. Sci. USA, 92, 9082-9086.
7. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA and Sutherland RL. (1993). Oncogene, 8, 2127-2133.
8. Chadeneau C, Siegel P, Harley CB, Muller WJ and Bacchetti S. (1995). Oncogene, 11, 893-898.
9. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Creider CW, Harley CB and Bacchetti S. (1992). EMBO J., 11, 1921-1929.
10. Das M, Mukhtar H, Bik DP and Bickers DR. (1987). Cancer Res., 47, 760-766.
11. Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W and Moore MAS. (1997). Proc. Natl. Acad. Sci. USA, 90, 182-193.
12. Greider CW. (1991). Cell, 67, 645-647.
13. Greider CW and Blackburn EH. (1985). Cell, 43, 405-413.
14. Hannon GJ and Beach D. (1994). Nature, 371, 257-261.
15. Holt SE, Aisner DL, Shay JW and Wright WE. (1997). Proc. Natl. Acad. Sci. USA, 94, 10687-10692.
16. Hunter T and Pines J. (1994). Cell, 79, 573-582.
17. Katiyar SK, Korman NJ, Mukhtar H and Agarwal R. (1997). J. Natl. Cancer Inst., 89, 556-566.
18. Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilczynski S, Lee YY, Bartram CR and Koeffler HP. (1995). Cancer Res., 55, 2266-2269.
19. Kim NW, Piatyszek MA, Prowse KR, Hurley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL and Shay JW. (1994). Science, 269, 2011-2015.
20. Landberg G, Nielsen NH, Nilsson P, Emdin SO, Cajander J and Roos G. (1997). Cancer Res., 57, 549-554.
21. Leach FS, Ellwdge SJ, Sherr CJ, Willson JKV, Markovitz S, Kinzler KW and Vogelstein B. (1993). Cancer Res., 53, 1986-1989.
22. Li R, Waga S, Hannon GJ, Beach D and Stillman B. (1994). Nature, 371, 534-537.
23. Linardopoulos S, Street AJ, Quelle DE, Parry D, Peters G, Sherr CJ and Balmain A. (1995). Cancer Res., 55, 5168-5172.
24. Pandita TK, Hall EJ, Hei TK, Piatyszek MA, Wright WE, Piao CQ, Pandita RK, Willey JC, Geard CR, Kastan MB and Shay JW. (1996). Oncogene, 13, 1423-1430.
25. Pardee AB. (1989). Science, 246, 603-608.
26. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM and Koff A. (1994). Genes Dev., 8, 9-22.
27. Ponce-Castaneda MV, Lee MH, Latres E, Polyak S, Lacombe L, Mongomery K, Mathew S, Krauter K, Sheinfeld J, Massague J and Carlos CC. (1995). Cancer Res., 55, 1211-1214.
28. Serrano M, Hannon GJ and Beach D. (1993). Nature, 366, 704-707.
29. Sgambato A, Han EKH, Zhang YJ, Moon RC, Santella RM and Weinstein IB. (1995). Carcinogenesis, 61, 2193-2198.
30. Sharma HW, Sokoloski JA, Perez JR, Maltese JY, Sartorelli AC, Stein CA, Nicholos G, Khaled Z, Telang NT and Narayanan R. (1995). Proc. Natl. Acad. Sci. USA, 92, 12343-12346.
31. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA and Shay JW. (1996). J. Invest. Dermatol., 106, 759-765.
32. Tron VA, Tang L, Yong WP and Trotter MJ. (1996). Am. J. Pathol., 149, 1139-1146.
33. Ueda M, Ouhtit A, Bito T, Nakazawa K, Lubbe J, Ichihashi M, Yamasaki H and Nakazama H. (1997). Cancer Res., 57, 370-374.
34. Whitaker NJ, Bryan TM, Bonnefin P, Chang AC, Musgrove EA, Braithwaite AW and Reddel RR. (1995). Oncogene, 11, 971-976.
35. Yashima K, Milchgrub S, Gollahon LS, Maitra A, Saboorian MH, Shay JW and Gazdar AF. (1998). Clin. Cancer Res., 4, 229-234.
36. Yoshimi N, Ino N, Suzui M, Hara A, Kei N, Sato S and Mori H. (1996). Mol. Carcinog., 16, 1-5.
37. Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohji H, Yamamoto H, Ide T and Utakoji T. (1996). Oncogene, 13, 433-439.
38. Zhang T, Nanney LB, Luongo C, Lamps L, Heppner KJ, Dubois R and Beauchamp RD. (1997). Cancer Res., 57, 169-175.
39. Zhou P, Jiang W, Zhang YJ, Khan SH, Schieren I, Santella RM and Weinstein IB. (1995). Oncogene, 11, 571-580.